Vaccines Bioprocess Development and Commercialisation

UCL Biochemical Engineering is excited to announce the MBI Vaccine Bioprocess Development and Commercialisation course. This course will assist in developing your knowledge on critical issues at each stage of vaccine development. Attendees hear from international experts about the research as well as operational and regulatory challenges facing the global vaccine market, while benefitting from excellent networking opportunities with peers over the duration of the course.

For any question, please reach out to mbi-training@ucl.ac.uk